Supratentorial Glioblastoma
Temozolomide and cis-retinoic acid with radiation evaluated in phase II study
Published in Clinical Oncology Week, May 30th, 2005
Neuro-oncologists in the United States conducted a study "to determine the median survival time of adults with supratentorial glioblastoma treated with a combination" of TMZ and cRA "given daily with conventional radiation therapy (XRT)."
"This was a single arm, open-labeled, Phase II study," explained N. Butowski and coauthors at the University of California-San Francisco. "Patients were treated with XRT in conjunction with cRA and TMZ."
"Both drugs were administered starting on Day 1 of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Leukemia
Efficacy of combining fludarabine with cyclophosphamide and mitoxantrone tested - Liver Cancer
Predictive value of CLIP, Okuda, TNM and JIS staging systems evaluated - Lung Cancer
Sleeve resection resulted in higher locoregional recurrence of lung cancer - Pediatric Cancer
High incidence of malformation syndromes correlated to pediatric cancer - Prostate Cancer
High dose rate (HDR) brachytherapy treated localized prostate cancer - Abdominal Cancer
Internal and externals markers correlated with abdominal tumor motion - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
